Hyafilia ME

Hyafilia ME

Within its category, Hyafilia ME has a straightforward role: deeper-fold correction and volume restoration. Its versatile correction profile and cross-linked hyaluronic acid formulation give practitioners a clearer basis for deciding when it fits, and when a neighbouring variant may be the better choice.

Where This Product Fits

The useful distinction is not simply that Hyafilia ME belongs to the dermal fillers category. Its value comes from the combination of formulation, presentation and treatment role.

• Hyafilia ME formulation: cross-linked hyaluronic acid, hyaluronic acid, and lidocaine
• Main professional objectives: deeper-fold correction and volume restoration
• Most relevant treatment areas: crow’s feet, chin, lips and perioral area, cheeks and midface, and nasolabial folds
• Presentation details: 1.0ml and 20mg/ml

1. Filler and Gel Profile

Hyafilia ME is positioned as the named formulation and presentation within its professional range. The relationship between its formulation, strength, presentation and professional objective defines this exact product more clearly than its category name alone.

2. How the Gel Supports Correction

Hyafilia ME is designed to provide physical support within professionally selected tissue planes. Its practical behaviour is linked to the gel profile: softer variants favour integration and refinement, while more structured variants are selected when projection, contour definition or volume replacement is the priority. This named variant balances correction and support according to its product profile.

3. Main Correction Goals

• Deep-fold correction

4. Facial Areas Suited to This Profile

Hyafilia ME is commonly associated with:

• Crow’s feet
• Chin
• Lips and perioral area
• Cheeks and midface
• Nasolabial folds
• Marionette lines
• Temples
• Nose
• Hands

Final placement and technique for Hyafilia ME follow the current product instructions and individual assessment.

5. Formulation and Syringe Specifications

The formulation includes cross-linked hyaluronic acid, hyaluronic acid, and lidocaine hydrochloride. The sealed label for Hyafilia ME remains the controlling reference for its exact ingredient statement.

• Product: Hyafilia ME
• Product type: Professional injectable dermal filler
• Hyafilia ME: Variant profile: The named formulation and presentation within its professional range
• Reported strength or volume: 20mg/mL and 1.0mL
• Hyafilia ME: Reported formulation: cross-linked hyaluronic acid, hyaluronic acid, and lidocaine hydrochloride
• Package details: 1.0mL syringe
• Storage profile: room-temperature storage is mentioned

6. Expected Integration and Result Profile

For Hyafilia ME, the visible profile is linked to the selected correction goal. Integration, projection and contour support should be assessed according to the named gel variant, treatment plane, area and quantity used rather than applying one duration claim to the entire product family.

7. Package and Storage Information

The reported package presentation includes 1.0mL syringe. The available product information specifies room-temperature storage is mentioned. The sealed outer box and current instructions remain the controlling handling reference.

8. Fine, Deep or Volume: Where This Variant Fits

this presentation should be compared with neighbouring variants by gel profile, not simply by brand name. Fine or Soft versions generally favour delicate refinement; Deep or Mid versions provide more support for folds and contour; Volume, Implant or Sub-Q versions sit toward structural correction and projection. this formulation is positioned as the named formulation and presentation within its professional range.

9. Frequently Asked Questions

What is Hyafilia ME?

For Hyafilia ME, this presentation is a professional injectable dermal filler positioned as the named formulation and presentation within its professional range. Its page is built around the exact formulation and presentation rather than a generic description of the category.

What is the main purpose of Hyafilia ME?

For this presentation, its product profile centres on deep-fold correction. The final treatment objective and technique are selected by a qualified professional.

What does Hyafilia ME contain?

For Hyafilia ME, for this formulation, available product information describes cross-linked hyaluronic acid, hyaluronic acid, and lidocaine hydrochloride.

Which areas are associated with Hyafilia ME?

The product information associates the named variant with crow’s feet, chin, lips and perioral area, cheeks and midface, nasolabial folds, marionette lines, temples, nose, and hands. Suitability and placement depend on the exact product instructions and individual assessment.

How is Hyafilia ME supplied?

the named variant is described with 1.0mL syringe. Current outer-box information remains the controlling reference for the received market presentation.

What makes this exact version different?

For Hyafilia ME, the named variant should be compared with neighbouring variants by gel profile, not simply by brand name. Fine or Soft versions generally favour delicate refinement; Deep or Mid versions provide more support for folds and contour; Volume, Implant or Sub-Q versions sit toward structural correction and projection. this presentation is positioned as the named formulation and presentation within its professional range.

10. Professional Use

Manufacturer-Confirmed Details

CHA Meditech’s official HYAFILIA information and product brochure establish HYAFILIA as a Korean cross-linked hyaluronic-acid filler range. The manufacturer’s current classic-range page lists 20mg/ml cross-linked HA, 1ml units and 1–30°C storage for named variants. Because “ME” is not presented identically on that page, those variant-specific specifications require confirmation from the exact ME carton or IFU.